Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Stefanie R. Lowas"'
Publikováno v:
Journal of Pediatric Hematology/Oncology. 43:e127-e129
Dinutuximab is a monoclonal antibody administered to patients with high-risk neuroblastoma, usually after an autologous stem cell transplant. Dinutuximab is associated with immune mediated and neurologic toxicities, but fatal adverse events are rare.
Autor:
Gabriel G. Malouf, Jose A. Karam, Chunkit Fung, W. Kimryn Rathmell, Kanishka Sircar, Jianjun Gao, Nizar M. Tannir, Daniel Y. Heng, Eric Jonasch, Ulka N. Vaishampayan, Amishi Yogesh Shah, Christopher G. Wood, Elizabeth A. Guancial, Pheroze Tamboli, Elizabeth R. Plimack, Priya Rao, Stefanie R. Lowas, Zita D. Lim, Lianchun Xiao, Surena F. Matin
Publikováno v:
BJU international. 120(6)
OBJECTIVE: To describe the management strategies and outcomes of patients with renal medullary carcinoma (RMC) and characterise predictors of overall survival (OS). PATIENTS AND METHODS: RMC is a rare and aggressive malignancy that afflicts young pat
Publikováno v:
Pediatric Blood & Cancer. 53:58-63
Background Pediatric acute lymphoblastic leukemia (ALL) therapies have been associated with many late effects, including obesity, hyperglycemia, and insulin resistance. Few data are available linking these abnormalities to specific risk factors prese
Publikováno v:
Pediatric bloodcancer. 50(5)
Late hemorrhagic disease of the newborn (HDN) presents 0.5-6 months after birth with mucocutaneous and intracranial bleeding. We describe here two cases of late HDN in infants who received vitamin K. The first case is a previously healthy breastfed m